Hotgen Biotech Injects RMB 300 Million into Subsidiary Sungen Bio for Biologic R&D
China’s Hotgen Biotech Co., Ltd (SHA: 688068) has announced a strategic capital injection plan, partnering...
Sungen Biomedical Technology
Beijing Sungen Biomedical’s SGC001 Receives FDA Fast Track Designation for AMI Treatment
China-based Beijing Sungen Biomedical Technology Co., Ltd, an antibody developer incubated by Hotgen Biotech Co.,...